Matthieu Moisse

Leuven, VLG 3000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

C21ORF2 mutations point towards primary cilia dysfunction in amyotrophic lateral sclerosis.

C21ORF2 mutations point towards primary cilia dysfunction in amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: April 21, 2024

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response.

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response.

Journal: Cell reports

Published: March 07, 2024

Genetic variability in sporadic amyotrophic lateral sclerosis.

Genetic variability in sporadic amyotrophic lateral sclerosis.

Journal: Brain : a journal of neurology

Published: November 16, 2022

Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data.

Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data.

Journal: Frontiers in cellular neuroscience

Published: September 21, 2022

Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis.

Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis.

Journal: Neurobiology of aging

Published: May 11, 2022

HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.

HNRNPK alleviates RNA toxicity by counteracting DNA damage in C9orf72 ALS.

Journal: Acta neuropathologica

Published: May 06, 2022

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS.

Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS.

Journal: Science translational medicine

Published: February 23, 2022

CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.

CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 04, 2022

Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.

Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.

Journal: Nature genetics

Published: February 01, 2022

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.

Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.

Journal: Molecular cancer

Published: January 10, 2022

Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer's Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene.

Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer's Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene.

Journal: International journal of molecular sciences

Published: November 26, 2021

Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis.

Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis.

Journal: International journal of molecular sciences

Published: September 21, 2021

Showing 1-12 of 66

Last Updated: 09/26/2026